Oxford Covid Trial

AstraZeneca, Oxford University resume Clinical trials of COVID-19 vaccines

Clinical trials of COVID-19 vaccines being developed by AstraZeneca and Oxford University have resumed in the United Kingdom after a brief safety pause. The trials resumed after the Medicines Health Regulatory Authority’s confirmed that the trials were safe. The human trials resumed days after a pause had been announced in the trials after an adverse reaction in one of the participants. AstraZeneca and the Oxford University confirmed that independent investigations concluded that the trials were safe to restart.

AstraZeneca said that all trial investigators and participants will be d with the relevant information and this will be disclosed on global clinical registries, according to the clinical trial and regulatory standards. According to the Oxford University scientists, of the hundreds of potential COVID-19 vaccines in development, six are in the final stages of testing, known as phase three clinical trials. 

By Naresh Sagar

Mentor MSME, Motivator, Media Event Org, Management fiscal & Water management.Social Media branding,Internet broadcasters,Propunder of Indian Philosophy

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s